A variant in KCNQ1 (rs163184) was found to be associated with a smaller reduction in HbA1c after 6 months of newly onset DPP-4i therapy in type 2 diabetes patients (0.3% reduction in response per each G allele) [18]. Here, KCNQ1 is linked to type 2 diabetes mellitus.